Lars Erik Larsson
Président chez Ellet Assets AB
Profil
Lars Erik Larsson is currently the Chairman at Ellet Assets AB and Fastighets AB.
Olshög.
He is also an Associate Professor at Umea Universitet.
In the past, he worked as the Medical Director at Astra Draco AB, Director at Wntresearch AB, Director at Cantargia AB, Director at Forskarpatent i Syd AB, Director at Cardio Vax LLC, and Senior Partner at TranScrip Partners LLP.
Additionally, Dr. Larsson was the Executive Director & Director-Medical Licensing at AstraZeneca R & D Lund from 1996 onwards.
Postes actifs de Lars Erik Larsson
| Sociétés | Poste | Début |
|---|---|---|
Ellet Assets AB
 Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Président | 07/03/2011 |
| AstraZeneca R & D Lund | Directeur/Membre du Conseil | 01/01/1996 |
| Umea Universitet | Corporate Officer/Principal | - |
| Fastighets AB Olshög | Président | - |
Anciens postes connus de Lars Erik Larsson
| Sociétés | Poste | Fin |
|---|---|---|
TranScrip Partners LLP
 TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Corporate Officer/Principal | - |
| Astra Draco AB | Directeur Technique/Scientifique/R&D | - |
| CANTARGIA AB | Directeur/Membre du Conseil | - |
Forskarpatent i Syd AB
 Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Directeur/Membre du Conseil | - |
| Cardio Vax LLC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WNTRESEARCH AB | Health Technology |
| CANTARGIA AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
Ellet Assets AB
Ellet Assets AB Miscellaneous Commercial ServicesCommercial Services Ellet Assets AB owns and manages real estate properties and securities. The company is headquartered in Lund, Sweden. | Commercial Services |
| Cardio Vax LLC | |
Forskarpatent i Syd AB
Forskarpatent i Syd AB Miscellaneous Commercial ServicesCommercial Services Forskarpatent i Syd AB specialises in the commercialisation, through licensing or new venture spinouts, of patentable inventions emanating mainly from Swedish universities. It holds a portfolio of projects in the format of shares in spinouts, partnered (licensed) and still unpartnered assets. It is involves in projects in pharmaceutical, technology, and food categories. The firm is categorized under patent agency operations. The company was founded on January 18, 1996 and is headquartered in Lund, Sweden. | Commercial Services |
| AstraZeneca R & D Lund | |
| Astra Draco AB | |
TranScrip Partners LLP
TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Health Technology |
| Fastighets AB Olshög |